(Q39748438)

English

The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo

scientific article

Statements

The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo (English)
Scott Ackler
Michael J Mitten
Kelly Foster
Anatol Oleksijew
Marion Refici
Stephen K Tahir
Yu Xiao
Christin Tse
David J Frost
Saul H Rosenberg
Steven W Elmore
Alexander R Shoemaker
23 January 2010
869-880

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit